Report ID: SQSG30I2032
Report ID:
SQSG30I2032 |
Region:
Global |
Published Date: February, 2024
Pages:
221
|
Tables:
69 |
Figures:
75
Global Carotenoids In Human Nutrition Market size was valued at USD 3.70 billion in 2022 and is poised to grow from USD 3.96 billion in 2023 to USD 6.86 billion by 2031, growing at a CAGR of 7.1% in the forecast period (2024-2031).
In terms of volume, the carotenoids in human nutrition market is projected to reach 0.1 million tons in 2019 at a CAGR of 5.98%. The industry is gaining traction, thanks to rising demand for carotenoids derived from natural sources. During the forecast period, it is expected to expand at the fastest CAGR in the carotenoids market.
This is due to a growing understanding of the potential advantages of carotenoids in avoiding heart disease, cancer, and treating eye illnesses such as Alzheimer's disease, Parkinson's disease, and macular degeneration. Furthermore, carotenoids have excellent antioxidant qualities and aid in the slowing of the ageing process. These advantages have made carotenoids a popular choice among consumers and food business participants. Furthermore, as consumer concern about the use of synthetic substances in food grows, customers throughout the world are demanding clean-label products. This has increased the need for natural colourants in the food sector, and carotenoids, a red pigment, are now commonly used in the meat industry to colour items such as salmon, trout, and other meat and seafood products.
US Carotenoids In Human Nutrition Market is poised to grow at a sustainable CAGR for the next forecast year.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQSG30I2032